CU23975B1 - - Google Patents

Info

Publication number
CU23975B1
CU23975B1 CU20100233A CU20100233A CU23975B1 CU 23975 B1 CU23975 B1 CU 23975B1 CU 20100233 A CU20100233 A CU 20100233A CU 20100233 A CU20100233 A CU 20100233A CU 23975 B1 CU23975 B1 CU 23975B1
Authority
CU
Cuba
Application number
CU20100233A
Other versions
CU20100233A7 (es
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CU20100233A priority Critical patent/CU23975B1/es
Publication of CU20100233A7 publication Critical patent/CU20100233A7/es
Publication of CU23975B1 publication Critical patent/CU23975B1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2278Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5146Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
CU20100233A 2010-12-01 2010-12-01 CU23975B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20100233A CU23975B1 (es) 2010-12-01 2010-12-01

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
CU20100233A CU23975B1 (es) 2010-12-01 2010-12-01
CA2819206A CA2819206C (en) 2010-12-01 2011-11-30 Use of pacap for treating viral infections in aquatic organisms
SG2013051289A SG191823A1 (en) 2010-12-01 2011-11-30 Use of pacap for treating viral infections in aquatic organisms
ES11807854.2T ES2621332T3 (es) 2010-12-01 2011-11-30 PACAP para el tratamiento de infecciones virales en organismos acuáticos
JP2013541202A JP5997702B2 (ja) 2010-12-01 2011-11-30 水生生物におけるウイルス感染を処置するためのpacapの使用
RU2013129830/13A RU2567802C2 (ru) 2010-12-01 2011-11-30 Применение расар для лечения вирусных инфекций у водных организмов
ARP110104456 AR084049A1 (es) 2010-12-01 2011-11-30 Uso del pacap para el tratamiento de infecciones virales en organismos acuaticos
KR1020137017000A KR101838721B1 (ko) 2010-12-01 2011-11-30 수중 생물에서 바이러스 감염을 치료하기 위한 pacap의 용도
US13/989,921 US9119830B2 (en) 2010-01-12 2011-11-30 Use of PACAP for the treatment of viral infections in aquatic organisms
BR112013013526A BR112013013526B1 (pt) 2010-12-01 2011-11-30 uso de pacap para o tratamento de infecções virais em organismos aquáticos, e combinação veterinária
AU2011335519A AU2011335519B2 (en) 2010-12-01 2011-11-30 Use of PACAP for treating viral infections in aquatic organisms
CN201180064517.1A CN103298452B (zh) 2010-12-01 2011-11-30 Pacap用于在水生生物中治疗病毒感染的用途
EP11807854.2A EP2647369B1 (en) 2010-12-01 2011-11-30 Pacap for the treatment of viral infections in aquatic organisms
MYPI2013700897A MY165435A (en) 2010-12-01 2011-11-30 Use of pacap for the treatment of viral infections in aquatic organisms
PT118078542T PT2647369T (pt) 2010-12-01 2011-11-30 Pacap para o tratamento de infeções virais em organismos aquáticos
PCT/CU2011/000008 WO2012072055A1 (es) 2010-12-01 2011-11-30 Uso del pacap para el tratamiento de infecciones virales en organismos acuaticos
MX2013006217A MX347844B (es) 2010-12-01 2011-11-30 Uso del pacap para el tratamiento de infecciones virales en organismos acuaticos.
ZA2013/04025A ZA201304025B (en) 2010-12-01 2013-05-31 Use of pacap for treating viral infections in aquatic organisms
CL2013001561A CL2013001561A1 (es) 2010-12-01 2013-05-31 Composicion que comprende al polipeptido activador de la adenilato ciclasa de pituitaria (pacap); combinacion veterinaria que comprende al pacap y una molecula antiviral; y uso del pacap para el tratamiento de enfermedades infecciosas causadas por virus en organismos acuaticos.
US14/839,114 US9603900B2 (en) 2010-12-01 2015-08-28 Use of PACAP for the treatment of viral infections in aquatic organisms

Publications (2)

Publication Number Publication Date
CU20100233A7 CU20100233A7 (es) 2012-10-15
CU23975B1 true CU23975B1 (es) 2014-01-29

Family

ID=45476244

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20100233A CU23975B1 (es) 2010-12-01 2010-12-01

Country Status (19)

Country Link
US (2) US9119830B2 (es)
EP (1) EP2647369B1 (es)
JP (1) JP5997702B2 (es)
KR (1) KR101838721B1 (es)
CN (1) CN103298452B (es)
AR (1) AR084049A1 (es)
AU (1) AU2011335519B2 (es)
BR (1) BR112013013526B1 (es)
CA (1) CA2819206C (es)
CL (1) CL2013001561A1 (es)
CU (1) CU23975B1 (es)
ES (1) ES2621332T3 (es)
MX (1) MX347844B (es)
MY (1) MY165435A (es)
PT (1) PT2647369T (es)
RU (1) RU2567802C2 (es)
SG (1) SG191823A1 (es)
WO (1) WO2012072055A1 (es)
ZA (1) ZA201304025B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105755014B (zh) * 2016-03-23 2019-03-19 中国科学院水生生物研究所 CaHV-TNFR特异基因及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695954A (en) * 1993-05-14 1997-12-09 University Of Victoria Innovation & Development Corporation DNA encoding two fish neuropeptides
CU23557A1 (es) * 2005-11-22 2010-07-20 Ct Ingenieria Genetica Biotech Neuropéptidos para el cultivo de organismos acuáticos

Also Published As

Publication number Publication date
KR20140031840A (ko) 2014-03-13
AU2011335519B2 (en) 2016-09-22
CN103298452B (zh) 2016-08-10
WO2012072055A1 (es) 2012-06-07
BR112013013526A2 (pt) 2016-10-18
CA2819206A1 (en) 2012-06-07
US20140087998A1 (en) 2014-03-27
MY165435A (en) 2018-03-22
JP2013544262A (ja) 2013-12-12
CL2013001561A1 (es) 2014-03-21
JP5997702B2 (ja) 2016-09-28
US9119830B2 (en) 2015-09-01
US9603900B2 (en) 2017-03-28
US20160030519A1 (en) 2016-02-04
BR112013013526B1 (pt) 2020-04-07
ES2621332T3 (es) 2017-07-03
MX2013006217A (es) 2013-07-15
EP2647369B1 (en) 2017-01-25
SG191823A1 (en) 2013-08-30
CU20100233A7 (es) 2012-10-15
PT2647369T (pt) 2017-04-11
KR101838721B1 (ko) 2018-03-14
RU2013129830A (ru) 2015-01-10
RU2567802C2 (ru) 2015-11-10
AR084049A1 (es) 2013-04-17
CN103298452A (zh) 2013-09-11
MX347844B (es) 2017-05-16
AU2011335519A1 (en) 2013-06-20
EP2647369A1 (en) 2013-10-09
CA2819206C (en) 2018-07-10
ZA201304025B (en) 2014-02-26

Similar Documents

Publication Publication Date Title
IN2012DN05920A (es)
CN102143559K1 (es)
IN2012DN06207A (es)
IN2012DN06575A (es)
IN2012DN05044A (es)
IN2012CN10925A (es)
IN2012DN06329A (es)
IN2011CH02897A (es)
IN2010CH03097A (es)
IN2012DN05167A (es)
IN2012DN05101A (es)
ECSDI109949S (es)
IN2012DN05067A (es)
IN2012DN04988A (es)
CN102195940K1 (es)
IN2012DN05905A (es)
IN2012DN00749A (es)
IN2012DN06306A (es)
CN102148803K1 (es)
CN101825970K1 (es)
CN101976565K1 (es)
IN2012DN04851A (es)
GB201103271D0 (es)
CN102271318K1 (es)
IN2011KO00284A (es)

Legal Events

Date Code Title Description
FG Grant of patent